Literature DB >> 11210988

Can survival be prolonged for patients with hormone-resistant prostate cancer?

A R Zlotta1, C C Schulman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11210988     DOI: 10.1016/S0140-6736(00)03633-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Reply by L. Maffioli.

Authors:  Lorenzo Maffioli; Luca Dellavedova; Luigia Florimonte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04       Impact factor: 9.236

2.  Radionuclide therapy of malignant bone lesions.

Authors:  M Fischer; H J Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-09       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.